102 related articles for article (PubMed ID: 32106239)
1. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.
Takasu M; Kondo S; Akiyama Y; Takahashi Y; Maeda S; Baba Y; Kawase T; Ichinohe T; Awai K
PLoS One; 2020; 15(2):e0229607. PubMed ID: 32106239
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Analysis of Whole-Body MRI for Accessing the Degree of Diffuse Infiltration Patterns and Identifying High Risk Cases of Newly Diagnosed Multiple Myeloma.
Sun M; Wang L; Wang C; Ma J; Wang W; Lin L; Ren C; Zhang Y; Cheng J
J Magn Reson Imaging; 2024 Jun; 59(6):2035-2045. PubMed ID: 37675995
[TBL] [Abstract][Full Text] [Related]
3. Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response.
Latifoltojar A; Hall-Craggs M; Rabin N; Popat R; Bainbridge A; Dikaios N; Sokolska M; Rismani A; D'Sa S; Punwani S; Yong K
Br J Haematol; 2017 Jan; 176(2):222-233. PubMed ID: 27766627
[TBL] [Abstract][Full Text] [Related]
4. The quantitative parameters based on marrow metabolism derived from synthetic MRI: A pilot study of prognostic value in participants with newly diagnosed multiple myeloma.
Cui S; Guo Y; Niu W; Li J; Bian W; Wu W; Zhang W; Zheng Q; Wang J; Niu J
Cancer Med; 2024 Apr; 13(7):e7109. PubMed ID: 38553942
[TBL] [Abstract][Full Text] [Related]
5. Apparent diffusion coefficient measurements of bone marrow infiltration patterns in multiple myeloma for the assessment of tumor burden - a feasibility study.
Xiong X; Ma Y; Dai Y; Hu C; Zhang Y
Radiol Oncol; 2023 Dec; 57(4):455-464. PubMed ID: 38038425
[TBL] [Abstract][Full Text] [Related]
6. Editorial for "Quantitative Analysis of Whole-Body MRI for Accessing the Degree of Diffuse Infiltration Patterns and Identifying High Risk Cases of Newly Diagnosed Multiple Myeloma".
Azlan CA; Md Shah MN
J Magn Reson Imaging; 2024 Jun; 59(6):2046-2047. PubMed ID: 37655837
[No Abstract] [Full Text] [Related]
7. Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx).
Phinyo P; Maihom T; Phanphaisarn A; Kerdsinchai P; Rattarittamrong E; Patumanond J; Pruksakorn D
BMC Fam Pract; 2020 Oct; 21(1):215. PubMed ID: 33087068
[TBL] [Abstract][Full Text] [Related]
8. The use of whole-body MRI in multiple myeloma.
Portet M; Owens E; Howlett D
Clin Med (Lond); 2019 Jul; 19(4):355-356. PubMed ID: 31308125
[No Abstract] [Full Text] [Related]
9. Editorial for "MRI Assessment of Renal Lipid Deposition and Abnormal Oxygen Metabolism of Type 2 diabetes Mellitus Based on mDixon-Quant".
Dekkers IA; Lamb HJ
J Magn Reson Imaging; 2023 Nov; 58(5):1418-1419. PubMed ID: 37002687
[No Abstract] [Full Text] [Related]
10. Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.
Zhang L; Wang Q; Wu X; Zhao A; Feng J; Zhang H; Cao X; Li S; Cai H; Sun Z; Duan M; Zhu T; Zhang W; Jin Z; Zhou D; Xue H; Li J
Eur Radiol; 2021 Apr; 31(4):1843-1852. PubMed ID: 32965573
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
[TBL] [Abstract][Full Text] [Related]
12. Marrow uptake on FDG PET/CT is associated with progression from smoldering to symptomatic multiple myeloma.
Amini B; Nakache YN; Nardo L; Manasanch EE; Sun J; Lenchik L; Boutin RD
Skeletal Radiol; 2021 Jan; 50(1):79-85. PubMed ID: 32621061
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bone marrow infiltration in multiple myeloma using whole-body diffusion-weighted imaging and T1-weighted water-fat separation Dixon.
Ji X; Huang W; Dong H; Shen Z; Zheng M; Zou D; Shen W; Xia S
Quant Imaging Med Surg; 2021 Feb; 11(2):641-651. PubMed ID: 33532264
[TBL] [Abstract][Full Text] [Related]
14. Quantitative bone marrow magnetic resonance imaging through apparent diffusion coefficient and fat fraction in multiple myeloma patients.
Berardo S; Sukhovei L; Andorno S; Carriero A; Stecco A
Radiol Med; 2021 Mar; 126(3):445-452. PubMed ID: 32812173
[TBL] [Abstract][Full Text] [Related]
15. Extended Texture Analysis of Non-Enhanced Whole-Body MRI Image Data for Response Assessment in Multiple Myeloma Patients Undergoing Systemic Therapy.
Ekert K; Hinterleitner C; Baumgartner K; Fritz J; Horger M
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32213834
[TBL] [Abstract][Full Text] [Related]
16. Does chemical shift imaging offer a biomarker for the diagnosis and assessment of disease severity in multiple myeloma?: A cross-sectional study.
Takasu M; Tanitame K; Baba Y; Akiyama Y; Tamura T; Kondo S; Maeda S; Sakai A; Awai K
Medicine (Baltimore); 2021 Feb; 100(6):e24358. PubMed ID: 33578532
[TBL] [Abstract][Full Text] [Related]
17. Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma.
Terao T; Machida Y; Tateishi U; Tsushima T; Narita K; Ikeda D; Fukumoto A; Kuzume A; Tabata R; Miura D; Takeuchi M; Matsue K
Sci Rep; 2021 Dec; 11(1):23978. PubMed ID: 34907317
[TBL] [Abstract][Full Text] [Related]
18. Prediction of mobilized hematopoietic stem cell yield in patients with multiple myeloma: Usefulness of whole-body MRI-derived indices.
Takasu M; Higashino R; Sueoka T; Kawai S; Tanitame N; Tamura A; Iida M; Kawase T; Ichinohe T; Awai K
PLoS One; 2023; 18(3):e0283241. PubMed ID: 37000837
[TBL] [Abstract][Full Text] [Related]
19. Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI.
Santoni A; Simoncelli M; Franceschini M; Ciofini S; Fredducci S; Caroni F; Sammartano V; Bocchia M; Gozzetti A
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579605
[TBL] [Abstract][Full Text] [Related]
20. Progress of modern imaging modalities in multiple myeloma.
Terao T; Matsue K
Int J Hematol; 2022 Jun; 115(6):778-789. PubMed ID: 35532876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
